-
Optimal Cutoff Values and Utility of High-Sensitivity Troponin T and NT-proBNP for the Risk Stratification of Patients with Acute Pulmonary Embolism Clin. Chem. (IF 7.1) Pub Date : 2024-12-20 Timothy M Matthews, Gregory A Peters, Grace Wang, Nora Horick, Kyle E Chang, Savanah Harshbarger, Christiana Prucnal, Drew A Birrenkott, Karsten Stannek, Eun Sang Lee, Isabel Dhar, Jesse O Wrenn, William B Stubblefield, Christopher Kabrhel
Background Guidelines recommend using high-sensitivity troponin T (hsTnT) and N-terminal pro-B-type natriuretic peptide (NT-proBNP) to risk stratify hemodynamically stable patients with acute pulmonary embolism (PE). However, there are no evidence-based cutoff values defined for this clinical application. Methods We performed a single-center, retrospective cohort study of patients with imaging-confirmed
-
Characterization of Cardiac Troponin Fragment Composition Reveals Potential for Differentiating Etiologies of Myocardial Injury Clin. Chem. (IF 7.1) Pub Date : 2024-12-19 Ling Li, Yuqing Liu, Ivan A Katrukha, Litao Zhang, Xin Shu, Ao Xu, Juan Yang, Yu Wu, Yisha Jing, Hui Wang, Tongxin Ni, Karen Schulz, Anastasia V Bereznikova, Alexey G Katrukha, Fred S Apple, Yi Zhang, Zhenlu Zhang
Background Increased cardiac troponin (cTn) concentrations occur in acute myocardial injury and chronic diseases. Characterization of cTn composition in the circulation may assist in differentiating etiologies of myocardial injury. Our goal was to study cTn composition and kinetics in patients following type 1 myocardial infraction (T1MI), cardiac procedures, and chronic heart diseases to establish
-
Design and Analytical Evaluation of Novel Cardiac Troponin Assays Targeting Multiple Forms of the Cardiac Troponin I-Cardiac Troponin T-Troponin C Complex and Fragmentation Forms. Clin. Chem. (IF 7.1) Pub Date : 2024-12-19 Ling Li,Yuqing Liu,Ivan A Katrukha,Litao Zhang,Xin Shu,Ao Xu,Juan Yang,Yu Wu,Yisha Jing,Hui Wang,Tongxin Ni,Karen Schulz,Anastasia V Bereznikova,Alexey G Katrukha,Fred S Apple,Yi Zhang,Zhenlu Zhang
BACKGROUND Current studies suggest that cardiac troponin (cTn) forms in the circulation may vary in different clinical scenarios. Our aim was to design a combination of cTn assays specific to the main cTn forms and to evaluate their analytical performance. METHODS We developed immunoassays specific for measuring (1) long-cTnT cTnI-cTnT-TnC (ITC) ternary complex, with cTnT in long form without cleavage
-
Advances in Cardiac Troponin Composition Assays: A Step Closer to the Clinic? Clin. Chem. (IF 7.1) Pub Date : 2024-12-19 Xander M R van Wijk,Sander A J Damen
-
An AI Model (LORIS) to Predict Immune Checkpoint Blockade Response in Cancer: A Clinical Data Science Perspective. Clin. Chem. (IF 7.1) Pub Date : 2024-12-17 Thomas E Tavolara,Wenchao Han,David S McClintock
-
Applications of Mass Spectrometry Proteomic Methods to Immunoglobulins in the Clinical Laboratory Clin. Chem. (IF 7.1) Pub Date : 2024-12-14 David L Murray, Maria A V Willrich
Background Immunoglobulin (Ig) measurements in the clinical laboratory have been traditionally performed by nephelometry, turbidimetry, electrophoresis, and ELISA assays. Mass spectrometry (MS) measurements have the potential to provide deeper insights on the nature of these markers. Content Different approaches—top-down, middle-down, or bottom-up—have been described for measuring specific Igs for
-
Measurement of Serum Free Vitamin D Concentrations: Importance, Challenges, and the Emerging Role of Mass Spectrometry Clin. Chem. (IF 7.1) Pub Date : 2024-12-11 Anastasia Alexandridou, Caroline S Stokes, Dietrich A Volmer
Background Serum total 25-hydroxyvitamin D [25(OH)D] concentration is the most widely used clinical biomarker for vitamin D status. Under certain physiological and pathological conditions, however, total 25(OH)D may not always be the best index for vitamin D status. Instead, the nonprotein-bound (free) fraction of total 25(OH)D has been suggested as a more appropriate marker in certain clinical situations
-
New Insights into Xylazine Pharmacokinetics in Humans. Clin. Chem. (IF 7.1) Pub Date : 2024-12-10 Kara L Lynch
-
Commentary on Progressive Motor Regression in a 3-Year-Old: Dietary Trends Revive an Overlooked Diagnosis. Clin. Chem. (IF 7.1) Pub Date : 2024-12-02 Ravinder Sodi
-
Commentary on Progressive Motor Regression in a 3-Year-Old: Dietary Trends Revive an Overlooked Diagnosis. Clin. Chem. (IF 7.1) Pub Date : 2024-12-02 Lawrence de Koning
-
Alkaline Phosphatase Activity Inconsistent with Patient's Clinical Presentation: A Cautionary Tale. Clin. Chem. (IF 7.1) Pub Date : 2024-12-02 Nicole J Mathewson,Kwaku Baryeh,Joseph W Rudolf,Vishnu Sundaresh,Vrajesh Pandya
-
Progressive Motor Regression in a 3-Year-Old: Dietary Trends Revive an Overlooked Diagnosis. Clin. Chem. (IF 7.1) Pub Date : 2024-12-02 Ashley R Rackow,Claire E Knezevic
-
Commentary on Alkaline Phosphatase Activity Inconsistent with Patient's Clinical Presentation: A Cautionary Tale. Clin. Chem. (IF 7.1) Pub Date : 2024-12-02 Isabelle Piec
-
Commentary on Alkaline Phosphatase Activity Inconsistent with Patient's Clinical Presentation: A Cautionary Tale. Clin. Chem. (IF 7.1) Pub Date : 2024-12-02 Christopher W Farnsworth
-
Validation of Analytical Performance Limits for Accuracy with High-Sensitivity Cardiac Troponin Assays. Clin. Chem. (IF 7.1) Pub Date : 2024-11-28 Peter A Kavsak,Alexander Kumaritakis,Matthew Wong-Fung,Tony Badrick,Michael Knauer
-
Virtual Gene Panels Have a Superior Diagnostic Yield for Inherited Rare Diseases Relative to Static Panels Clin. Chem. (IF 7.1) Pub Date : 2024-11-21 Massomeh Sheikh Hassani, Ruchi Jain, Sathishkumar Ramaswamy, Shruti Sinha, Maha El Naofal, Nour Halabi, Sawsan Alyafei, Roudha Alfalasi, Shruti Shenbagam, Alan Taylor, Ahmad Abou Tayoun
Background Exome- or genome-based panels—also known as slices or virtual panels—are now a popular approach that involves comprehensive genomic sequencing while restricting analysis to subsets of genes based on patients’ phenotypes. This flexible strategy enables frequent gene updates based on novel disease associations as well as reflexing to analyzing other genes up to the whole exome or genome. With
-
Xylazine Pharmacokinetics in Patients Testing Positive for Fentanyl and Xylazine. Clin. Chem. (IF 7.1) Pub Date : 2024-11-20 Yanchun Lin,Christopher W Farnsworth,Vahid Azimi,David B Liss,Michael E Mullins,Bridgit O Crews
BACKGROUND The increasing prevalence of xylazine in the illicit drug supply is a growing concern for major health consequences in individuals who use fentanyl mixed with xylazine, but limited data are available regarding the pharmacokinetics of xylazine in humans. METHODS Xylazine was quantified in serial remnant plasmas collected from 28 patients starting at the initial patient encounter and continuing
-
Prospective and External Validation of an Ensemble Learning Approach to Sensitively Detect Intravenous Fluid Contamination in Basic Metabolic Panels Clin. Chem. (IF 7.1) Pub Date : 2024-11-15 Nicholas C Spies, Leah Militello, Christopher W Farnsworth, Joe M El-Khoury, Thomas J S Durant, Mark A Zaydman
Background Intravenous (IV) fluid contamination within clinical specimens causes an operational burden on the laboratory when detected, and potential patient harm when undetected. Even mild contamination is often sufficient to meaningfully alter results across multiple analytes. A recently reported unsupervised learning approach was more sensitive than routine workflows, but still lacked sensitivity
-
Mosaic Copy Number Variation in a Patient with Cerebral and Pulmonary Arteriovenous Malformations and Recurrent Epistaxis. Clin. Chem. (IF 7.1) Pub Date : 2024-11-04 Sharri S Cyrus,Michelle L Kluge,Cherisse A Marcou,Erik C Thorland,Vivek N Iyer,Linnea M Baudhuin
-
Commentary on Mosaic Copy Number Variation in a Patient with Cerebral and Pulmonary Arteriovenous Malformations and Recurrent Epistaxis. Clin. Chem. (IF 7.1) Pub Date : 2024-11-04 Anne B S Giersch
-
Estimating Reference Change Values Using Routine Patient Data: A Novel Pathology Database Approach Clin. Chem. (IF 7.1) Pub Date : 2024-11-04 Eirik Åsen Røys, Kristin Viste, Ralf Kellmann, Nora Alicia Guldhaug, Bashir Alaour, Marit Sverresdotter Sylte, Janniche Torsvik, Heidi Strand, Michael Marber, Torbjørn Omland, Elvar Theodorsson, Graham Ross Dallas Jones, Kristin Moberg Aakre
Background The reference change value (RCV) is calculated by combining the within-subject biological variation (CVI) and local analytical variation (CVA). These calculations do not account for the variation seen in preanalytical conditions in routine practice or CVI in patients presenting for treatment. As a result, the RCVs may not reflect routine practice or align with clinicians’ experiences. We
-
dmTGS: Precise Targeted Enrichment Long-Read Sequencing Panel for Tandem Repeat Detection Clin. Chem. (IF 7.1) Pub Date : 2024-11-04 Kang Yang, Yue Liu, Ji Zhang, Qian Yu, Feng Xu, Jiyuan Liu, Yuting Li, Xiaojie Zhang, Zhiqiang Wang, Ning Wang, Yuezhen Li, Yan Shi, Wan-Jin Chen
Background Tandem repeats (TRs) are abundant in the human genome and associated with repeat expansion disorders. Our study aimed to develop a tandem repeat panel utilizing targeted long-read sequencing to evaluate known TRs associated with these disorders and assess its clinical utility. Methods We developed a targeted long-read sequencing panel for 70 TR loci, termed dynamic mutation third-generation
-
Adiponectin and Risk of Psoriasis: Observational and Mendelian Randomization Studies in up to 900 000 Individuals Clin. Chem. (IF 7.1) Pub Date : 2024-10-31 Maria B Nielsen, Marianne Benn, Børge G Nordestgaard, Lone Skov, Yunus Çolak
Background Psoriasis is a chronic inflammatory skin disorder often associated with obesity. Adiponectin, an anti-inflammatory protein-hormone secreted by adipose tissue, may be a link between obesity and psoriasis. We hypothesized that low plasma adiponectin is associated with an increased risk of psoriasis in observational and causal genetic studies. Methods In observational analyses, we used information
-
Forever Chemicals, Endless Testing? Expert Advice to Be Prepared for Per- and Polyfluoroalkyl Substances. Clin. Chem. (IF 7.1) Pub Date : 2024-12-02 Frederick G Strathmann,Susan Burden,Jenna Hua,Andrew Patterson,Robert Middleberg
-
Rethinking Albuminuria in Low-Risk Patients and a Call for Urine Albumin Standardization. Clin. Chem. (IF 7.1) Pub Date : 2024-10-28 Jesse C Seegmiller,Joachim H Ix
-
Machine Learning-Based Detection of Bladder Cancer by Urine cfDNA Fragmentation Hotspots that Capture Cancer-Associated Molecular Features Clin. Chem. (IF 7.1) Pub Date : 2024-10-21 Xiang-Yu Meng, Xiong-Hui Zhou, Shuo Li, Ming-Jun Shi, Xuan-Hao Li, Bo-Yu Yang, Min Liu, Ke-Zhen Yi, Yun-Ze Wang, Hong-Yu Zhang, Jian Song, Fu-Bing Wang, Xing-Huan Wang
Background cfDNA fragmentomics-based liquid biopsy is a potential option for noninvasive bladder cancer (BLCA) detection that remains an unmet clinical need. Methods We assessed the diagnostic performance of cfDNA hotspot-driven machine-learning models in a cohort of 55 BLCA patients, 51 subjects with benign conditions, and 11 healthy volunteers. We further performed functional bioinformatics analysis
-
Mass Spectrometry Meets Free Light Chains: A Path toward Greater Diagnostic Precision. Clin. Chem. (IF 7.1) Pub Date : 2024-12-02 Maria Alice Vieira Willrich
-
Correction to: Ready, Set, Screen: The Role of the Clinical Laboratory in Eliminating Chronic Hepatitis B Infection. Clin. Chem. (IF 7.1) Pub Date : 2024-12-02
-
Proteomic Signature of BMI and Risk of Cardiovascular Disease Clin. Chem. (IF 7.1) Pub Date : 2024-10-11 Hao Ma, Xuan Wang, Yoriko Heianza, JoAnn E Manson, Lu Qi
Background Obesity, defined by body mass index (BMI) alone, is a metabolically heterogeneous disorder with distinct cardiovascular manifestations across individuals. This study aimed to investigate the associations of a proteomic signature of BMI with risk of major subtypes of cardiovascular disease (CVD). Methods A total of 40 089 participants from UK Biobank, free of CVD at baseline, had complete
-
Deconvolution of Human Urine across the Transcriptome and Metabolome. Clin. Chem. (IF 7.1) Pub Date : 2024-11-04 Sevahn K Vorperian,Brian C DeFelice,Joseph A Buonomo,Hagop J Chinchinian,Ira J Gray,Jia Yan,Kathleen E Mach,Vinh La,Timothy J Lee,Joseph C Liao,Richard Lafayette,Gabriel B Loeb,Carolyn R Bertozzi,Stephen R Quake
BACKGROUND Early detection of the cell type changes underlying several genitourinary tract diseases largely remains an unmet clinical need, where existing assays, if available, lack the cellular resolution afforded by an invasive biopsy. While messenger RNA in urine could reflect the dynamic signal that facilitates early detection, current measurements primarily detect single genes and thus do not
-
Clonality Determination by Detecting Unmodified Monoclonal Serum Free Light Chains Using On-Probe Extraction Coupled with Liquid Chromatography-High-Resolution Mass Spectrometry. Clin. Chem. (IF 7.1) Pub Date : 2024-12-02 Priscilla S W Yeung,Yajing Liu,Samuel Yang,Ashley Ruan,Christina R Kerr,Carolyn V Wong,Run-Zhang Shi,David J Iberri,Ruben Y Luo
BACKGROUND Serum free light chains (FLCs) are an essential clinical biomarker for the diagnosis and monitoring of patients with plasma cell neoplasms. The current widely used immunoassay methods quantify total serum FLCs, which include monoclonal FLCs as well as FLCs in the polyclonal background. Patients with chronic diseases, inflammatory disorders, or renal dysfunction can have elevated total FLCs
-
Beyond the Screen-Positive Rate: Racial Equity Considerations for Serum Screening for Open Neural Tube Defects. Clin. Chem. (IF 7.1) Pub Date : 2024-12-02 Christina C Pierre,Dina N Greene,Daniel S Herman,Octavia M Peck Palmer,Shani Delaney
-
In Reply to Beyond the Screen Positive Rate: Racial Equity Considerations for Serum Screening for Open Neural Tube Defects. Clin. Chem. (IF 7.1) Pub Date : 2024-12-02 Geralyn Messerlian,Glenn E Palomaki
-
Untargeted Metabolomics for Inborn Errors of Metabolism: Development and Evaluation of a Sustainable Reference Material for Correcting Inter-Batch Variability Clin. Chem. (IF 7.1) Pub Date : 2024-10-04 Rafael Garrett, Adam S Ptolemy, Sara Pickett, Mark D Kellogg, Roy W A Peake
Background Untargeted metabolomics has shown promise in expanding screening and diagnostic capabilities for inborn errors of metabolism (IEMs). However, inter-batch variability remains a major barrier to its implementation in the clinical laboratory, despite attempts to address this through normalization techniques. We have developed a sustainable, matrix-matched reference material (RM) using the iterative
-
Alzheimer Disease Blood-Based Biomarkers: Translation from Research into Clinical Use. Clin. Chem. (IF 7.1) Pub Date : 2024-11-04 Lance A Ladic,Mari L DeMarco,Nicholas J Ashton,Andrew J Saykin,Louis B Jacques
-
Commentary on Negative Sweat Chloride Testing in the Setting of a Positive Newborn Screen and CFTR Compound Heterozygosity. Clin. Chem. (IF 7.1) Pub Date : 2024-10-03 Adrienne Savant
-
ADLM 2024 Annual Scientific Meeting Abstracts: Bold Advancements in Laboratory Medicine. Clin. Chem. (IF 7.1) Pub Date : 2024-10-03 Christina C Pierre,Joshua Hayden,Mark A Marzinke
-
Approval of the First CRISPR-Cas9 Gene Editing Therapy for Sickle Cell Disease. Clin. Chem. (IF 7.1) Pub Date : 2024-10-03 Sean T Campbell
-
Commentary on Negative Sweat Chloride Testing in the Setting of a Positive Newborn Screen and CFTR Compound Heterozygosity. Clin. Chem. (IF 7.1) Pub Date : 2024-10-03 Mark A Cervinski
-
An Interference That Makes You Blue? Clin. Chem. (IF 7.1) Pub Date : 2024-10-03 Ruth Melka,Christopher W Farnsworth,Yanchun Lin
-
Personalized Reproductive Hormone Monitoring in Sweat. Clin. Chem. (IF 7.1) Pub Date : 2024-10-03 Robert D Maynard
-
Negative Sweat Chloride Testing in the Setting of a Positive Newborn Screen and CFTR Compound Heterozygosity. Clin. Chem. (IF 7.1) Pub Date : 2024-10-03 Lucille De Maria,Marion Marlinge,Melisande Baravalle,Jean-Christophe Dubus,Julien Fromonot
-
B-195 Accelerating Molecular Diagnostics: Development of a novel Rapid, Integrated PCR System for Acute Respiratory Infections Detection Clin. Chem. (IF 7.1) Pub Date : 2024-10-02 T Ma, L Dong, H Chen, Z Lv, J Chen, Y Yang
Background The COVID-19 pandemic and acute respiratory infections have underscored the necessity for high-throughput and timely molecular diagnostics. Existing molecular diagnostic methods are labor-intensive, a challenge particularly evident in large-scale testing. This study aims to streamline the nucleic acid testing process by integrating extraction and detection in PCR testing, thereby optimizing
-
B-316 Evaluation of an FDA-cleared Chromogranin A Assay on an Automated Analyzer Clin. Chem. (IF 7.1) Pub Date : 2024-10-02 N Boyert, G Schroeder, M Dee, J M Colon-Franco
Background Chromogranin A (CgA) is a hydrophilic and acidic protein, present in the chromaffin granules of neuroendocrine cells. It is the preferred tumor marker for the monitoring of neuroendocrine tumors (NETS), which are often found in the lungs, appendix, pancreas, and gastrointestinal tract. Previous CgA assays were performed by manual ELISA testing, and were not FDA-approved, leading to a longer
-
B-205 Performance of a Novel Fluorogenic Assay for Detection of Carbapenemase-producing Enterbacteriaceae Clin. Chem. (IF 7.1) Pub Date : 2024-10-02 Z Zhou, S Li, D Jiang, Z Wang, Y Wang, Y Zhang, H Wang, Y Su
Background In recent years, under the selective challenge of antibiotics, the variety and number of drugresistant pathogenic microorganisms have increased significantly, which brings great challenges to clinical diagnosis and treatment, especially the infection caused by carbapenem resistant Enterobacteriaceae (CRE). Carbapenemases production is the main mechanism of drug resistance of Enterobacteriaceae
-
B-200 Expediting Identification of Occult Sepsis with a Novel Diagnostic for Patients Presenting to the ED with Possible Infection Clin. Chem. (IF 7.1) Pub Date : 2024-10-02 T Jagneaux, A Grantham, K Richard, C Thomas, C D’Antonio, M Laperouse, R Scoggins, H O’Neal
Background In August 2023 Our Lady of the Lake Regional Medical Center implemented a process for sepsis care based on a novel sepsis diagnostic (IntelliSep) in the Emergency Department (ED). As a component of our Sepsis Learning Health Program, we continually evaluate this process. Methods A nurse-driven protocol allows for IntelliSep ordering with triage assessment. Dependent upon bed availability
-
B-170 Age-Specific reference intervals for ethanolamine plasmalogen species in red blood cells using liquid chromatography tandem mass spectrometry Clin. Chem. (IF 7.1) Pub Date : 2024-10-02 I De Biase, M Miller, L M Zuromski, S Steckel, P P Vachali, T Yuzyuk
Background Plasmalogens are critical membrane structural components that are mainly generated by de novo synthesis starting in peroxisomes. Hence, patients with defects in peroxisome biogenesis (PBD) exhibit markedly reduced plasmalogen levels. Plasmalogen ratios are traditionally measured by gas chromatography-mass spectrometry (GC-MS); however, this method entails a lengthy sample extraction and
-
B-131 The fallacy of average sigma levels from mixed sample levels Clin. Chem. (IF 7.1) Pub Date : 2024-10-02 Z BROOKS
Background Sigma measures the number of SDs (z-value) from the existing sample mean to the nearest analytical performance standard or allowable error limit. Authors and software programs often measure sigma metrics for each QC sample but use an average sigma to compare methods and select QC strategies. That practice leads to dramatic over or under-estimation of the number of errors reported and the
-
B-119 Comparative performance of GPT-4 and CNV-ETLAI in extracting copy number variations from medical journals: Bridging the gap between large language models and specialized NLP tools in genomic data interpretation Clin. Chem. (IF 7.1) Pub Date : 2024-10-02 J Choi
Background Copy Number Variations (CNVs) are critical genetic markers in diversity and disease, yet their accurate extraction from medical literature remains challenging due to the complexity of genetic data. While specialized NLP models like CNV-ETLAI have been developed for this task, the advent of Large Language Models (LLMs) such as GPT-4 presents a potential alternative with broader applicability
-
B-068 Plasma calprotectin as an index of draining tunnel formation in Hidradenitis suppurativa Clin. Chem. (IF 7.1) Pub Date : 2024-10-02 A Havelka, T Kanni, E J Giamarellos-Bourboulis
Background Hidradenitis suppurativa (HS) is a chronic, inflammatory skin disease which affects areas rich in apocrine glands. The main disease manifestations are inflammatory nodules (IN) and draining tunnels (dT). The course and progression of the disease are difficult to predict. There is currently lack of any broadly accepted biomarker which may inform on the activity of hidradenitis suppurativa
-
B-169 Combining the EXENT System and LC-MS for the Detection of Monoclonal Immunoglobulins at Low Levels Clin. Chem. (IF 7.1) Pub Date : 2024-10-02 D R Barnidge, D Troske, S North, G Wallis, M Perkins, S Harding
Background The EXENT® system is an automated platform designed to quantify monoclonal immunoglobulins in serum. EXENT® combines immunoprecipitation and MALDI-TOF mass spectrometry for the detection of monoclonal immunoglobulins at levels lower than traditional gel based methods. This study was designed to demonstrate if EXENT® prepared samples that were negative could be reflexed to a more sensitive
-
B-179 Comparative Evaluation of Cisplatin Release from Alginate Hydrogels with Embedded Silver Nanoparticles: An HPLC and Colorimetric Spectrophotometry Study Clin. Chem. (IF 7.1) Pub Date : 2024-10-02 H Kalil, S Maher, M Bayachou
Background Cisplatin [cis-dichlorodiamine platinum (II)], is a well-recognized chemotherapeutical drug. Cisplatin has been employed in treating a wide range of human cancers, such as those of the breast, bladder, lung, ovarian, and testicular cancers. Its therapeutic action is attributed to its capacity to form crosslinks with the DNA's purine bases, disrupting DNA repair processes, causing DNA damage
-
A-345 Effect of Hemolysis on Routine Blood Gas Analytes Clin. Chem. (IF 7.1) Pub Date : 2024-10-02 B Agana, B Overton, K Florendo, C Knezevic
Background Hemolysis is a major pre-analytical concern for most laboratory analytes. Detection of hemolysis and mitigation efforts are especially important for analytes, such as potassium, with high intracellular concentrations. Routine serum and plasma chemistry tests are performed on analyzers with the capacity to detect and measure the degree of hemolysis. However, for whole blood chemistries and
-
A-296 Streck Urine Preserve Provides Sample Stability for Cepheid Xpert CT/NG test Clin. Chem. (IF 7.1) Pub Date : 2024-10-02 C M Connelly, J Li
Background Sexually transmitted infections (STIs) are one of the most common communicable diseases worldwide and are associated with significant morbidity and mortality. Data indicates that the four curable STIs - chlamydia, gonorrhea, trichomoniasis, and syphilis - cause over 375 million infections annually. Further, the infection rate for gonorrhea has increased by 63% in the United States and the
-
A-331 Monitoring Operators Proficiency at Point of Care is Crucial for Reliable Patient Values. A Practical Example with Patient Blood Chloride, Potassium and Sodium Measurands Assayed with i-STAT® Clin. Chem. (IF 7.1) Pub Date : 2024-10-02 V Genta, C M Aston, F M Alferes, P M Darville, S Shumate
Background While i-STAT® cartridges offer the Physician a spectrum of analytical methods at the point of care for prompt diagnosis and interventions, these methods have to be harmonized with the laboratory methods in order to reliably detect shifts and trends. With this practical example we illustrate the importance of a program of routine comparisons between the i-STAT® and laboratory methods to detect
-
A-319 Capillary Blood Collection for Egg-cellent Reproductive Insights Clin. Chem. (IF 7.1) Pub Date : 2024-10-02 W C Brandon, B B Collier, M R Chappell, G Iacovetti, M Peevler, U Y Schaff, G J Sommer, R P Grant
Background In the United States, an estimated 13% of women between the ages of 15 and 49 years, experience impaired reproductive potential (fecundity). Assessment of fecundity typically requires an in-person physician visit and venous blood collection to evaluate hormone levels and identify potential reproductive health conditions. Exploring less invasive, at-home sampling options could offer couples
-
A-302 Evaluation of real-time PCR assays for detection of sexually-transmitted infections Clin. Chem. (IF 7.1) Pub Date : 2024-10-02 H Soong
Background Sexually transmitted infections (STIs) have serious negative consequences for reproductive health worldwide. They are associated with infertility, premature birth and neonatal infections. Five STI pathogens, namely Trichomonas vaginalis, Mycoplasma genitalium, Mycoplasma hominis, Ureaplasma parvum, and Ureaplasma urealyticum were selected for the evaluation of three potential real-time PCR
-
A-205 Evaluating the Cost and Importance of Supply Chain Resilience in the Clinical Laboratory Clin. Chem. (IF 7.1) Pub Date : 2024-10-02 E Jurinic
Background Recent pandemics, epidemics and outbreaks continually underscore the critical importance of resilient supply chains in healthcare, particularly in clinical laboratories where timely access to supplies is essential for patient care. Supply chain disruptions, whether due to global crises or localized challenges, can significantly impact laboratory operations, leading to delayed diagnoses,
-
B-244 Analytical Performance and Method Comparison Evaluation of a New High Throughput Fully Automated Plasma GFAP Immunoassay Clin. Chem. (IF 7.1) Pub Date : 2024-10-02 Z Vucetic, M Szabo, M Salvati, B Schlichtmann, J Patzlaff, D Unruh, K Curtis, L Mediger, M Nichkova-Doseva
Background Glial Fibrillary Acidic Protein (GFAP) levels are shown to be an indicator of neurologic injury in conditions like Traumatic Brain Injury (TBI) and stroke and as a marker of disease progression in neuromuscular disorders such as multiple sclerosis. Plasma GFAP is also implicated in detecting AD pathology, correlating to the clinical stage of the disease. The performance characteristics of
-
A-237 Analytical Performance Evaluation of Cytomegalovirus IgG and Syphilis Assays on the Atellica CI Analyzer Clin. Chem. (IF 7.1) Pub Date : 2024-10-02 M Quintanilla, B Valdivia, L Halik, G Arrode-Bruses, H Leipold
Background The Atellica® CI Analyzer is an automated, high-throughput integrated chemistry and immunoassay analyzer utilizing both Atellica® CH and Atellica® IM Assays. This study evaluated the analytical performance of the Atellica IM Cytomegalovirus IgG (CMV IgG) and Syphilis (Syph) Assays on the Atellica CI Analyzer. Methods Precision studies were performed according to CLSI EP05-A3 using native